CURRENT INCIDENCE AND ESTIMATED RESIDUAL RISK OF TRANSFUSION-TRANSMITTED HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN QINGDAO, CHINA

被引:0
|
作者
Feng, Q. [1 ]
Zhou, B. [1 ]
机构
[1] Qingdao Blood Ctr, Qingdao, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:94 / 94
页数:1
相关论文
共 50 条
  • [41] Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus
    Seed, CR
    Kiely, P
    Keller, AJ
    INTERNAL MEDICINE JOURNAL, 2005, 35 (10) : 592 - 598
  • [42] Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey
    Velati, Claudio
    Romano, Luisa
    Piccinini, Vanessa
    Marano, Giuseppe
    Catalano, Liviana
    Pupella, Simonetta
    Facco, Giuseppina
    Pati, Ilaria
    Tosti, Maria Elena
    Vaglio, Stefania
    Grazzini, Giuliano
    Zanetti, Alessandro
    Liumbruno, Giancarlo M.
    BLOOD TRANSFUSION, 2018, 16 (05) : 422 - 432
  • [44] Transfusion-transmitted virus infection in children with chronic hepatitis C
    Giacchino, R
    Bortolotti, F
    Resti, M
    Tasso, L
    Crivellaro, C
    Azzari, C
    Sinelli, N
    Picciotto, A
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (12) : 1213 - 1214
  • [45] Fatal outcome of a hepatitis B virus transfusion-transmitted infection
    Niederhauser, C.
    Weingand, T.
    Candotti, D.
    Maier, A.
    Tinguely, C.
    Wuillemin, W. A.
    Gowland, P.
    Allain, J. P.
    Stolz, M.
    VOX SANGUINIS, 2010, 98 (04) : 504 - 507
  • [46] RESIDUAL RISK OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 TRANSMITTED BY TRANSFUSION IN SHANGHAI, 2005 THROUGH 2008
    Wang, X.
    Li, X. M.
    Jia, Y.
    Zheng, L.
    Qian, K. C.
    Zhu, Y. M.
    VOX SANGUINIS, 2010, 99 : 119 - 120
  • [47] Impact of Multiplex PCR in Reducing the Risk of Residual Transfusion-Transmitted Human Immunodeficiency and Hepatitis B and C Viruses in Burkina Faso
    Yooda, Arzouma Paul
    Soubeiga, Serge Theophile
    Nebie, K. Yacouba
    Diarra, Birama
    Sawadogo, Salam
    Ouattara, Abdoul Karim
    Obiri-Yeboah, Dorcas
    Yonli, Albert Theophane
    Tao, Issoufou
    Sorgho, Pegdwende Abel
    Dahourou, Honorine
    Simpore, Jacques
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2018, 10
  • [48] Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil
    de Miranda Correa, Angelita Silva
    Lamarao, Leticia Martins
    Moura Vieira, Priscilla Cristina
    Hermes de Castro, Renata Bezerra
    Costa de Almeida, Nubia Caroline
    Americo de Castro, Jairo Augusto
    Maciel de Lima, Maria Salete
    Palmeira, Mauricio Koury
    Langanke Pedroso Meireles, Ana Luiza
    Burbano, Rommel Rodriguez
    PLOS ONE, 2018, 13 (12):
  • [49] Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon
    Tagny, Claude Tayou
    Mbanya, Dora
    Leballais, Lionel
    Murphy, Edward
    Lefrere, Jean-Jacques
    Laperche, Syria
    TRANSFUSION, 2011, 51 (01) : 184 - 190
  • [50] Transfusion-transmitted human immunodeficiency virus infection by a Danish blood donor with a very low viral load in the preseroconversion window phase
    Harritshoj, Lene H.
    Dickmeiss, E.
    Hansen, M. Bagge
    Ullurn, H.
    Jorgensen, L. Bruun
    Gerstoft, J.
    TRANSFUSION, 2008, 48 (09) : 2026 - 2028